183 related articles for article (PubMed ID: 19284072)
1. Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II.
Vaina S; Voudris V; Morice MC; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Schuijer M; Macours N; Stoll HP; Cokkinos DV; Stefanadis C; Serruys PW;
EuroIntervention; 2009 Jan; 4(4):492-501. PubMed ID: 19284072
[TBL] [Abstract][Full Text] [Related]
2. Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study.
Garg S; Sarno G; Gutiérrez-Chico JL; Garcia-Garcia HM; Gomez-Lara J; Serruys PW;
EuroIntervention; 2011 Apr; 6(9):1060-7. PubMed ID: 21518677
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II).
Kukreja N; Serruys PW; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Goedhart D; Macours N; Stoll HP;
Heart; 2009 Jul; 95(13):1061-6. PubMed ID: 19304671
[TBL] [Abstract][Full Text] [Related]
4. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
van Domburg RT; Daemen J; Morice MC; de Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; van Es GA; Wittebols K; Macours N; Stoll HP; Serruys PW
EuroIntervention; 2010 Apr; 5(8):962-7. PubMed ID: 20542782
[TBL] [Abstract][Full Text] [Related]
6. The gender paradox.
Presbitero P
EuroIntervention; 2009 Jan; 4(4):415, 417. PubMed ID: 19284061
[No Abstract] [Full Text] [Related]
7. Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.
Rodriguez AE; Maree A; Tarragona S; Fernandez-Pereira C; Santaera O; Rodriguez Granillo AM; Rodriguez-Granillo GA; Russo-Felssen M; Kukreja N; Antoniucci D; Palacios IF; Serruys PW;
EuroIntervention; 2009 Jun; 5(2):255-64. PubMed ID: 20449934
[TBL] [Abstract][Full Text] [Related]
8. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
[TBL] [Abstract][Full Text] [Related]
9. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.
Serruys PW; Onuma Y; Garg S; Vranckx P; De Bruyne B; Morice MC; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Schuijer M; Rademaker T; Wittebols K; Stoll HP;
J Am Coll Cardiol; 2010 Mar; 55(11):1093-101. PubMed ID: 20171036
[TBL] [Abstract][Full Text] [Related]
10. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
[TBL] [Abstract][Full Text] [Related]
11. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
Wijnbergen I; Helmes H; Tijssen J; Brueren G; Peels K; van Dantzig JM; Van' t Veer M; Koolen JJ; Pijls NH; Michels R
JACC Cardiovasc Interv; 2012 Mar; 5(3):313-22. PubMed ID: 22440498
[TBL] [Abstract][Full Text] [Related]
12. 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials.
Onuma Y; Wykrzykowska JJ; Garg S; Vranckx P; Serruys PW;
JACC Cardiovasc Interv; 2011 Mar; 4(3):317-23. PubMed ID: 21435610
[TBL] [Abstract][Full Text] [Related]
13. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
[TBL] [Abstract][Full Text] [Related]
14. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
15. Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
Serruys PW; Daemen J; Morice MC; De Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; Dawkins KD; Vranckx P; Bressers M; van Domburg R; Schuijer M; Wittebols K; Pieters M; Stoll HP
EuroIntervention; 2008 Jan; 3(4):450-9. PubMed ID: 19736087
[TBL] [Abstract][Full Text] [Related]
16. Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II).
Routledge HC; Lefèvre T; Colombo A; Oldroyd KG; Hamm CW; Guagliumi G; von Scheidt W; Guetta V; Ruzyllo W; Wittebols K; Goedhart DM; Serruys PW
EuroIntervention; 2009 Jun; 5(2):190-6. PubMed ID: 20449929
[TBL] [Abstract][Full Text] [Related]
17. Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).
Spaulding C; Teiger E; Commeau P; Varenne O; Bramucci E; Slama M; Beatt K; Tirouvanziam A; Polonski L; Stella PR; Clugston R; Fajadet J; de Boisgelin X; Bode C; Carrié D; Erglis A; Merkely B; Hosten S; Cebrian A; Wang P; Stoll HP; Henry P
JACC Cardiovasc Interv; 2011 Jan; 4(1):14-23. PubMed ID: 21251624
[TBL] [Abstract][Full Text] [Related]
18. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
19. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of percutaneous coronary intervention and coronary artery bypass grafts for ostial right coronary lesions in propensity-matched individuals.
Gan HL; Zhang JQ; Huang F; Gu CX; Kong QY; Cao XR; Bo P; Lu CS
Cardiovasc Ther; 2011 Dec; 29(6):395-403. PubMed ID: 20718758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
